Inhibrx Biosciences Inc. (NASDAQ: INBX) is 4.60% higher on its value in year-to-date trading and has touched a low of $10.80 and a high of $18.95 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The INBX stock was last observed hovering at around $13.91 in the last trading session, with the day’s gains setting it 0.65%.
Currently trading at $14.56, the stock is 15.37% and 8.78% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.15 million and changing 4.67% at the moment leaves the stock 3.85% off its SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.07% in the last 1 month and extending the period to 3 months gives it a -10.40%, and is 9.15% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.20% over the week and 6.14% over the month.
Distance from 52-week low is 34.81% and -23.17% from its 52-week high.
.
Inhibrx Biosciences Inc. (INBX) Top Institutional Holders
The shares outstanding are 14.48M, and float is at 10.22M with Short Float at 7.37%.
The top institutional shareholder in the company is DEKABANK DEUTSCHE GIROZENTRALE with over 26400.0 shares valued at $0.93 million. The investor’s holdings represent 0.0484% of the INBX Shares outstanding. As of 2024-06-30, the second largest holder is ADVISOR GROUP HOLDINGS, INC. with 6690.0 shares valued at $$0.23 million to account for 0.0123 of the shares outstanding.
Inhibrx Biosciences Inc. (INBX) Insider Activity
The most recent transaction is an insider purchase by MANHARD KIMBERLY,the company’sDirector. SEC filings show that MANHARD KIMBERLY bought 10,000 shares of the company’s common stock on Aug 28 ’24 at a price of $13.98 per share for a total of $0.14 million. Following the purchase, the insider now owns 10000.0 shares.
Inhibrx Biosciences Inc. disclosed in a document filed with the SEC on Aug 23 ’24 that FORSYTH DOUGLAS (Director) bought a total of 59,812 shares of the company’s common stock. The trade occurred on Aug 23 ’24 and was made at $14.07 per share for $0.84 million. Following the transaction, the insider now directly holds 0.22 million shares of the INBX stock.
Still, SEC filings show that on Aug 22 ’24, FORSYTH DOUGLAS (Director) acquired 15,188 shares at an average price of $12.89 for $0.2 million. The insider now directly holds 164,752 shares of Inhibrx Biosciences Inc. (INBX).
